Literature DB >> 29055960

MicroRNA-145 Aggravates Hypoxia-Induced Injury by Targeting Rac1 in H9c2 Cells.

Ximing Wang1, Yanxia Zhang2, Hongshan Wang1, Genshang Zhao1, Xianen Fa1.   

Abstract

BACKGROUND/AIMS: Myocardial infarction (MI) is a leading cause of morbidity and mortality. Here, we sought to explore the potential role and underlying mechanism of miR-145 in MI.
METHODS: H9c2 cells were cultured under persistent hypoxia to simulate MI. The hypoxia-induced injury was assessed on the basis of cell viability, migration, invasion and apoptosis. The expression of miR-145 was evaluated by qRT-PCR and the influence of aberrantly expressed miR-145 on H9c2 cells under hypoxia was also estimated. Utilizing bioinformatics methods, the target genes of miR-145 were verified by luciferase reporter assay. Then, effects of abnormally expressed target gene on miR-145 silenced H9c2 cells were assessed. Finally, the phosphorylation levels of key kinases in the phosphatidylinositol-3-kinase (PI3K)/AKT and the mitogen-activated protein kinase (MAPK)/extracellular signal-regulated kinase (ERK) pathways were detected by Western blot analysis.
RESULTS: Hypoxia remarkably lowered viability, migration and invasion but promoted cell apoptosis. Meantime, the miR-145 level was up-regulated in H9c2 cells under hypoxia. Following experiments suggested that hypoxia-induced injury was exacerbated by miR-145 overexpression while was alleviated by miR-145 silence. Rac1 was predicted and further validated to be a target gene of miR-145. The influence of miR-145 silencing on H9c2 cells under hypoxia could be reversed by down-regulation of Rac1. Additionally, the phosphorylation levels of PI3K, AKT, MAPK and ERK were all elevated in miR-145 silenced cells and these alterations were reversed by down-regulation of Rac1.
CONCLUSION: miR-145 silencing could protect H9c2 cells against hypoxia-induced injury by targeting Rac1, in which PI3K/AKT and MAPK/ERK pathways might be involved.
© 2017 The Author(s). Published by S. Karger AG, Basel.

Entities:  

Keywords:  Hypoxia-induced injury; MAPK/ERK; MiR-145; Myocardial infarction; PI3K/AKT; Rac1

Mesh:

Substances:

Year:  2017        PMID: 29055960     DOI: 10.1159/000484121

Source DB:  PubMed          Journal:  Cell Physiol Biochem        ISSN: 1015-8987


  5 in total

1.  miR-145-5p targets paxillin to attenuate angiotensin II-induced pathological cardiac hypertrophy via downregulation of Rac 1, pJNK, p-c-Jun, NFATc3, ANP and by Sirt-1 upregulation.

Authors:  Yu-Lan Yeh; Kuan-Ho Lin; V Bharath Kumar; Tamilselvi Shanmugam; Marthandam Asokan Shibu; Ray-Jade Chen; Chia-Hua Kuo; Tsung-Jung Ho; V Vijaya Padma; Chih-Yang Huang
Journal:  Mol Cell Biochem       Date:  2021-04-22       Impact factor: 3.396

2.  The biomarkers of key miRNAs and target genes associated with acute myocardial infarction.

Authors:  Qi Wang; Bingyan Liu; Yuanyong Wang; Baochen Bai; Tao Yu; Xian-Ming Chu
Journal:  PeerJ       Date:  2020-05-13       Impact factor: 2.984

3.  Modulation of miR-145-5p and miR-146b-5p levels is linked to reduced parasite load in H9C2 Trypanosoma cruzi infected cardiomyoblasts.

Authors:  Priscila Silva Grijó Farani; Beatriz Iandra Silva Ferreira; Daniel Gibaldi; Joseli Lannes-Vieira; Otacilio Cruz Moreira
Journal:  Sci Rep       Date:  2022-01-26       Impact factor: 4.379

4.  Identification and characterization of differentially expressed miRNAs in HepG2 cells under normoxic and hypoxic conditions.

Authors:  Fanzhi Kong; Wei Ran; Ning Jiang; Shize Li; Dongjie Zhang; Dongbo Sun
Journal:  RSC Adv       Date:  2019-05-29       Impact factor: 3.361

5.  LncRNA MALAT1 up-regulates VEGF-A and ANGPT2 to promote angiogenesis in brain microvascular endothelial cells against oxygen-glucose deprivation via targetting miR-145.

Authors:  Lanfen Ren; Chunxia Wei; Kui Li; Zuneng Lu
Journal:  Biosci Rep       Date:  2019-03-06       Impact factor: 3.840

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.